-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Amneal Pharmaceuticals, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q1 2020.
- Amneal Pharmaceuticals, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2020 was $0.000.
- Amneal Pharmaceuticals, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $0.000.
- Amneal Pharmaceuticals, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $0.000.
- Amneal Pharmaceuticals, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $0.000.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)